Product Name: DOC1 antibody
Applications: WB
Predicted Target Size: 130 kDa (note) (5)
Positive Controls: HCT116 , MCF-7
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: filamin A interacting protein 1-like
Background: Acts as a regulator of the antiangiogenic activity on endothelial cells. When overexpressed in endothelial cells, leads to inhibition of cell proliferation and migration and an increase in apoptosis. Inhibits melanoma growth When expressed in tumor-associated vasculature.
Synonyms: DOC-1 antibody, DOC1 antibody, GIP90 antibody, FILIP1L antibody, 130 kDa GPBP-interacting protein antibody, 90 kDa GPBP-interacting protein antibody, GPBP-interacting protein 90 antibody, downregulated in ovarian cancer 1 81 kDa isoform antibody, protein down-regulated in ovarian cancer 1 antibody, filamin A-interacting protein 1-like antibody, GPBP-interacting protein of 130 kDa antibody, filamin A interacting protein 1-like antibody
Cellular Localization: Cytoplasm , Membrane , Nucleus
CAS NO: 1210344-57-2
Product: Bicalutamide
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the N-terminus region of human DOC1. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22216254?dopt=Abstract
